BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20210280)

  • 1. Termination of amblyopia treatment: when to stop follow-up visits and risk factors for recurrence.
    De Weger C; Van Den Brom HJ; Lindeboom R
    J Pediatr Ophthalmol Strabismus; 2010; 47(6):338-46. PubMed ID: 20210280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term vision outcomes of conventional treatment of strabismic and anisometropic functional amblyopia.
    Garoufalis P; Georgievski Z; Koklanis K
    Binocul Vis Strabismus Q; 2007; 22(1):49-56. PubMed ID: 17417966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of visual acuity in a historical cohort of 137 patients treated for amblyopia by occlusion 30-35 years ago].
    Simonsz-Tóth B; Loudon SE; van Kempen-du Saar H; van de Graaf ES; Groenewoud JH; Simonsz HJ
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):40-6. PubMed ID: 17260318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
    Loudon SE; Polling JR; Simonsz HJ
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):176-80. PubMed ID: 12644939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The method of treatment cessation and recurrence rate of amblyopia.
    Walsh LA; Hahn EK; LaRoche GR
    Strabismus; 2009 Sep; 17(3):107-16. PubMed ID: 20804358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of contour integration in relation to LogMAR visual acuity during treatment of amblyopia in children.
    Chandna A; Gonzalez-Martin JA; Norcia AM
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4016-22. PubMed ID: 15505051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia.
    Levartovsky S; Oliver M; Gottesman N; Shimshoni M
    Br J Ophthalmol; 1995 Mar; 79(3):225-8. PubMed ID: 7703198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the stability of visual function following cessation of occlusion therapy for amblyopia.
    Tacagni DJ; Stewart CE; Moseley MJ; Fielder AR
    Graefes Arch Clin Exp Ophthalmol; 2007 Jun; 245(6):811-6. PubMed ID: 17047980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of occlusion amblyopia after prescribed full-time occlusion on long-term visual acuity outcomes.
    Longmuir S; Pfeifer W; Scott W; Olson R
    J Pediatr Ophthalmol Strabismus; 2013; 50(2):94-101. PubMed ID: 23205770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment.
    Arikan G; Yaman A; Berk AT
    Strabismus; 2005 Jun; 13(2):63-9. PubMed ID: 16020359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of amblyopia after occlusion therapy.
    Bhola R; Keech RV; Kutschke P; Pfeifer W; Scott WE
    Ophthalmology; 2006 Nov; 113(11):2097-100. PubMed ID: 17074568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of penalization methods in moderate to mild amblyopia.
    Tejedor J; Ogallar C
    Am J Ophthalmol; 2008 Mar; 145(3):562-9. PubMed ID: 18207121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual prognosis of amblyopia associated with myelinated retinal nerve fibers.
    Kee C; Hwang JM
    Am J Ophthalmol; 2005 Feb; 139(2):259-65. PubMed ID: 15733986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with recurrence of amblyopia on cessation of patching.
    Holmes JM; Melia M; Bradfield YS; Cruz OA; Forbes B;
    Ophthalmology; 2007 Aug; 114(8):1427-32. PubMed ID: 17363058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the outcome of children treated for amblyopia.
    Woodruff G; Hiscox F; Thompson JR; Smith LK
    Eye (Lond); 1994; 8 ( Pt 6)():627-31. PubMed ID: 7867817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior chamber toric phakic IOL implantation for the management of pediatric anisometropic amblyopia.
    Althomali TA
    J Refract Surg; 2013 Jun; 29(6):396-400. PubMed ID: 23586373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual functions and interocular interactions in anisometropic children with and without amblyopia.
    Lai XJ; Alexander J; He M; Yang Z; Suttle C
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6849-59. PubMed ID: 21775663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preverbal photoscreening for amblyogenic factors and outcomes in amblyopia treatment: early objective screening and visual acuities.
    Kirk VG; Clausen MM; Armitage MD; Arnold RW
    Arch Ophthalmol; 2008 Apr; 126(4):489-92. PubMed ID: 18413517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical translation of recommendations from randomized clinical trials on patching regimen for amblyopia.
    Jin YP; Chow AH; Colpa L; Wong AM
    Ophthalmology; 2013 Apr; 120(4):657-62. PubMed ID: 23395531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amblyopia therapy initiated after 9 years of age.
    Park KH; Hwang JM; Ahn JK
    Eye (Lond); 2004 Jun; 18(6):571-4. PubMed ID: 15184922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.